REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07224022 updates: 1. start date: 2026-07-01 → 2026-10-01 2. completion date: 2029-11-30 → 2029-06-30 3. primary completion date: 2028-08-31 → 2028-12-31
Clinical trial NCT07224022 updates: 1. start date: 2026-07-01 → 2026-10-01 2. completion date: 2029-11-30 → 2029-06-30 3. primary completion date: 2028-08-31 → 2028-12-31
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical